Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines.
about
Protective effect of a prime-boost strategy with the Ts87 vaccine against Trichinella spiralis infection in miceProtection against salmonella typhimurium, salmonella gallinarum, and salmonella enteritidis infection in layer chickens conferred by a live attenuated salmonella typhimurium strain.Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.A vaccine candidate for post-weaning diarrhea in swine constructed with a live attenuated Salmonella delivering Escherichia coli K88ab, K88ac, FedA, and FedF fimbrial antigens and its immune responses in a murine modelComparison between Immunization Routes of Live Attenuated Salmonella Typhimurium Strains Expressing BCSP31, Omp3b, and SOD of Brucella abortus in Murine Model.Live attenuated Salmonella displaying HIV-1 10E8 epitope on fimbriae: systemic and mucosal immune responses in BALB/c mice by mucosal administration.Salmonella enterica as a vaccine carrier.Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice.Generation of an attenuated strain oral vaccine candidate using a novel double selection platform in Escherichia coli.Salmonella ghosts expressing enterotoxigenic Escherichia coli k88ab, k88ac, k99, and fasa fimbrial antigens induce robust immune responses in a mouse model.Expression of avian infectious bronchitis virus multi-epitope based peptide EpiC in Lactococcus lactis for oral immunization of chickens.The efficacy, biodistribution and safety of an inhibin DNA vaccine delivered by attenuated Salmonella choleraesuis.Salmonella Vaccines: Conduits for Protective Antigens.Live attenuated Salmonella typhimurium vaccines delivering SaEsxA and SaEsxB via type III secretion system confer protection against Staphylococcus aureus infection.
P2860
Q34183489-F50C2F78-D2D3-46FA-A5B6-DBDC7A67A999Q35113312-78180F21-7B90-452D-AAC1-184D48BCD79FQ35689514-3A40AD79-A9B0-400A-9ED4-C36150ECCE23Q36061825-E0E662E4-AFB0-4A1D-A76B-D880E501D087Q36814216-52876672-7045-410C-92AC-AF4A11834564Q37093244-1442BBB4-2F43-4274-BACA-145923E94A40Q37970705-EACD264C-3547-46F6-BF2D-6B73FC3A8A68Q41475755-03683F9F-643F-4321-B9EC-274C3A747FC8Q41707204-397D3F30-2C2B-43FF-8EBF-CC1807BBCA8BQ42174414-139B1D8F-0F7D-4D49-A6E9-E350921BA2F0Q44285945-EC4FEC76-C819-48E8-A17E-17104CAAC934Q47111326-CEEEE1E7-C692-40FE-882E-AAD94BF402B2Q49644946-D1134F35-80E9-4AF9-86A6-E41107041130Q55278118-AE750DFC-B766-481C-AB1A-579E926BC149
P2860
Effect of expression level on immune responses to recombinant oral Salmonella enterica serovar Typhimurium vaccines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of expression level on ...... serovar Typhimurium vaccines.
@en
Effect of expression level on ...... serovar Typhimurium vaccines.
@nl
type
label
Effect of expression level on ...... serovar Typhimurium vaccines.
@en
Effect of expression level on ...... serovar Typhimurium vaccines.
@nl
prefLabel
Effect of expression level on ...... serovar Typhimurium vaccines.
@en
Effect of expression level on ...... serovar Typhimurium vaccines.
@nl
P2093
P2860
P1433
P1476
Effect of expression level on ...... serovar Typhimurium vaccines.
@en
P2093
James J Kohler
Latha Pathangey
Ryutaro Isoda
Thomas A Brown
P2860
P304
P356
10.1016/J.VACCINE.2009.02.072
P407
P577
2009-03-03T00:00:00Z